Ignite Creation Date:
2024-05-06 @ 10:19 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03226132
Status:
COMPLETED
Last Update Posted:
2021-02-01
First Post:
2017-07-13
Brief Title:
Improving Sleep to Reduce Risk for Substance Use Disorder
Sponsor:
Florida State University
Organization:
Florida State University
Study Overview
Official Title:
Biobehavioral Mechanisms Underlying Improving Sleep to Reduce Risk for Substance Use Disorder
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Substance use disorders SUDs are a prevalent and impairing condition particularly among trauma exposed individuals The current proposal aims to address the critical need for targeted direct SUD prevention in this population by intervening on a novel malleable risk factor for SUD common among trauma-exposed individuals sleep disturbance Sleep disturbance prospectively predicts the development of SUD and may confer risk for SUD by increasing stress reactivity decreasing decision-making abilities and ultimately promoting substance use to relieve negative affect a core etiological factor in SUD However to our knowledge no experimental studies have determined whether improving sleep leads to reductions in SUD risk As such the current study will use a randomized controlled trial design to test the effects of brief behavioral treatment for insomnia BBTI against a waitlist control among a sample of trauma-exposed young adults with poor sleep and risk for SUD N 60 We aim to determine the direct and indirect effects of condition BBTI vs waitlist control on SUD symptoms substance use-related problems coping motives and posttraumatic stress symptoms through improvements in sleep Furthermore we will test direct and indirect effects of condition on theoretically proposed mechanisms underlying the association between sleep disturbance and SUD risk ie stress reactivity cravings in response to stress
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None